PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Emmanuel Ifeanyi Obeagu

University of the Witwatersrand

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 8, 2026 · JOURNAL ARTICLE

Engineering probiotic consortia to improve chemotherapy tolerance and reduce toxicity in breast cancer patients: a new frontier in supportive precision oncology

Oncology Reviews

This is a narrative review synthesizing mechanistic rationale and emerging evidence for a novel intervention; it raises questions about engineered probiotic consortia rather than reporting definitive efficacy data from controlled trials.

Hypothesis-GeneratingEmmanuel Ifeanyi Obeagu Cancer Cells and Metastasis Cancer Research and Treatments

Study details

DesignNarrative review

InterventionEngineered probiotic consortia (multi-strai…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support